Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan

被引：15
|
作者：
Saito, H. [1 ]
Tani, Y. [2 ]
Ozaki, A. [2 ,5 ]
Sawano, T. [3 ]
Shimada, Y. [4 ]
Yamamoto, K. [2 ]
Tanimoto, T. [2 ]
机构：
[1] Sendai Kousei Hosp, Dept Gastroenterol, Sendai, Miyagi, Japan
[2] Med Governance Res Inst, Minato Ku, Tokyo, Japan
[3] Minamisoma Municipal Gen Hosp, Dept Surg, Fukushima, Japan
[4] Minamisoma Municipal Gen Hosp, Dept Neurosurg, Fukushima, Japan
[5] Tokiwa Fdn, Jyoban Hosp, Dept Breast Surg, Iwaki, Fukushima, Japan
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2019年 / 25卷 / 11期
关键词：
Clinical practice guidelines; Financial conflicts of interest; Methicillin-resistant Staphylococcus aureus guidelines; Payments database; Transparency; INDUSTRY;
D O I：
10.1016/j.cmi.2019.07.025
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1304 / 1306
页数：3
相关论文
共 50 条
  • [1] Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan
    Yamamoto, Kana
    Murayama, Anju
    Ozaki, Akihiko
    Saito, Hiroaki
    Sawano, Toyoaki
    Tanimoto, Tetsuya
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2021, 32 (02) : 443 - 451
  • [2] Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan
    Kana Yamamoto
    Anju Murayama
    Akihiko Ozaki
    Hiroaki Saito
    Toyoaki Sawano
    Tetsuya Tanimoto
    [J]. International Urogynecology Journal, 2021, 32 : 443 - 451
  • [3] Financial payments made by pharmaceutical companies to the authors of Japanese hematology clinical practice guidelines between 2016 and 2017
    Harada, Kayo
    Ozaki, Akihiko
    Saito, Hiroaki
    Sawano, Toyoaki
    Yamamoto, Kana
    Murayama, Anju
    Senoo, Yuki
    Tanimoto, Tetsuya
    [J]. HEALTH POLICY, 2021, 125 (03) : 320 - 326
  • [4] Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines
    Mitchell, Aaron P.
    Mishra, Akriti
    Dey, Pranam
    Curry, Michael A.
    Trivedi, Niti U.
    Haddadin, Michael
    Rahman, Mohammed W.
    Winn, Aaron N.
    Dusetzina, Stacie B.
    Bach, Peter B.
    [J]. ONCOLOGIST, 2021, 26 (09): : 771 - 778
  • [5] Relationships between authors of clinical practice guidelines and the pharmaceutical industry
    Choudhry, NK
    Stelfox, HT
    Detsky, AS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (05): : 612 - 617
  • [6] Undisclosed financial conflicts of interest with pharmaceutical companies among the authors of the Esophageal Cancer Practice Guidelines 2017 by the Japan Esophageal Society
    Murayama, Anju
    Kamamoto, Sae
    Shigeta, Haruki
    Saito, Hiroaki
    Yamashita, Erika
    Tanimoto, Tetsuya
    Akihiko, Ozaki
    [J]. DISEASES OF THE ESOPHAGUS, 2022, 35 (10)
  • [7] Financial conflicts of interest between infectious diseases clinical practice guideline authors and the pharmaceutical industry in Japan
    Murayama, Anju
    Shin, Naoki
    Higuchi, Kenichi
    Kohli, Isha
    Kugo, Hinari
    Senoo, Yuki
    [J]. INFECTIOUS DISEASES, 2024, 56 (04) : 330 - 334
  • [8] Financial ties and conflicts of interest between pharmaceutical and tobacco companies
    Shamasunder, B
    Bero, L
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (06): : 738 - 744
  • [9] Financial conflicts of interest among authors of clinical practice guidelines for diabetes mellitus in Japan
    Murayama, Anju
    [J]. JOURNAL OF DIABETES, 2024, 16 (04)
  • [10] Financial Conflicts of Interest Among the Authors of the Clinical Practice Guidelines for Rheumatoid Arthritis in Japan
    Murayama, Anju
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
12345